(The Center Square) – In its ongoing fight against identity politics in medicine, Do No Harm exposed the American Medical Association this week for content related to identity politics and diversity, equity and inclusion in its Continuing Medical Education courses.
(The Center Square) – The American Nurses Association is urging the public to call for nurses to be added back into the definition of “professional degrees” after the Trump administration removed the designation amid new federal loan borrowing caps.
(The Center Square) – Medical group Do No Harm released a report Tuesday that it says debunks a study on racial concordance, with a Do No Harm leader stating that matching a patient with a doctor of the same race does not improve medical outcomes.
(The Center Square) – The United States completed its withdrawal from the World Health Organization due to the group’s mishandling of the COVID-19 pandemic, with a medical group praising the move and officials stating the withdrawal is for those who died alone in nursing homes and whose businesses were destroyed due to COVID responses induced by WHO.
(The Center Square) – President Donald Trump and senior health administration officials touted the $50 billion set aside in the One Big Beautiful Bill for rural health care during a round table Friday, saying it will transform the care available to rural Americans.
(The Center Square) – Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday.
(The Center Square) - A detransitioner is sharing her story with The Center Square and speaking out in strong support of Health and Human Services Secretary Robert F. Kennedy series of regulatory actions designed to block access to gender altering drugs and surgical procedures for minors.
(The Center Square) – A U.S. Department of Health and Human Services spokesman says Illinois Gov. J.B. Pritzker eroded public trust and is trying to reinvent public health.
Graham A. Colditz, MD, Deputy Director, Institute for Public Health, is photographed at FLTC on March 15, 2022.
In 2023, a federal appeals court ruled that nothing in federal law prevents pharmacy manufacturers from limiting the number of contract pharma…
